James Chalmers to Hospitalization
This is a "connection" page, showing publications James Chalmers has written about Hospitalization.
Connection Strength
0.285
-
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J. 2021 04; 57(4).
Score: 0.099
-
The economic burden of bronchiectasis - known and unknown: a systematic review. BMC Pulm Med. 2019 Feb 28; 19(1):54.
Score: 0.086
-
Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study. Chest. 2017 06; 151(6):1247-1254.
Score: 0.074
-
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 31; 21(1):691.
Score: 0.006
-
Economic burden of bronchiectasis in Germany. Eur Respir J. 2019 02; 53(2).
Score: 0.005
-
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Lancet Respir Med. 2019 03; 7(3):213-226.
Score: 0.005
-
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respir Med. 2018 04; 137:6-13.
Score: 0.005
-
The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective Bronchiectasis. Chest. 2018 05; 153(5):1177-1186.
Score: 0.005